Koga K - Search Results

1

Effective use of the cuffed oropharyngeal airway.

Koga K, Kaku M, Sata T, Shigematsu A. Koga K, et al. Anaesthesia. 1998 Jul;53(7):715-6. doi: 10.1046/j.1365-2044.1998.537g-az0584g.x. Anaesthesia. 1998. PMID: 9771188 Free article. No abstract available.

2

Should epidurals be avoided in acupunctured patients?

Koga K, Shigematsu A, Noguchi T, Shiga Y. Koga K, et al. Anaesthesia. 2001 Mar;56(3):291-2. doi: 10.1046/j.1365-2044.2001.01918-28.x. Anaesthesia. 2001. PMID: 11251464 Free article. No abstract available.

3

Comparison of no airway device, the Guedel-type airway and the Cuffed Oropharyngeal Airway with mask ventilation during manual in-line stabilization.

Koga K, Sata T, Kaku M, Takamoto K, Shigematsu A. Koga K, et al. J Clin Anesth. 2001 Feb;13(1):6-10. doi: 10.1016/s0952-8180(00)00228-2. J Clin Anesth. 2001. PMID: 11259887 Clinical Trial.

4

[Effects of various lidocaine compounds on cuff pressure of a reinforced tracheal tube].

Koga K, Sata T, Shigematsu A. Koga K, et al. Masui. 1999 Dec;48(12):1314-7. Masui. 1999. PMID: 10658410 Japanese.

5

A method to improve a gas leak on mask ventilation in the patient with a nasogastric tube.

Noguchi T, Shiga Y, Koga K, Shigematsu A. Noguchi T, et al. Among authors: koga k. Anesthesiology. 2001 Mar;94(3):545. doi: 10.1097/00000542-200103000-00041. Anesthesiology. 2001. PMID: 11374627 Free article. Clinical Trial. No abstract available.

6

Use of the cuffed oropharyngeal airway after difficult ventilation through a facemask.

Asai T, Koga K, Stacey MR. Asai T, et al. Among authors: koga k. Anaesthesia. 1997 Dec;52(12):1236-7. Anaesthesia. 1997. PMID: 9485992 Free article. No abstract available.

7

The cuffed oropharyngeal airway. Its clinical use in 100 patients.

Asai T, Koga K, Jones RM, Stacey M, Latto IP, Vaughan RS. Asai T, et al. Among authors: koga k. Anaesthesia. 1998 Aug;53(8):817-22. doi: 10.1046/j.1365-2044.1998.00524.x. Anaesthesia. 1998. PMID: 9797528 Free article. Clinical Trial.

8

Role of nitric oxide during carrageenan-sensitized endotoxin shock in mice.

Koga K, Sata T, Nanri H, Sano H, Ikeda M, Shigematsu A. Koga K, et al. Life Sci. 1995;57(25):2309-16. doi: 10.1016/0024-3205(95)02225-8. Life Sci. 1995. PMID: 7491089

9

An antagonist of platelet-activating factor suppresses endotoxin-induced tumor necrosis factor and mortality in mice pretreated with carrageenan.

Ogata M, Matsumoto T, Koga K, Takenaka I, Kamochi M, Sata T, Yoshida S, Shigematsu A. Ogata M, et al. Among authors: koga k. Infect Immun. 1993 Feb;61(2):699-704. doi: 10.1128/iai.61.2.699-704.1993. Infect Immun. 1993. PMID: 8423096 Free PMC article.

10

[Results of treatment of out-of-hospital cardiopulmonary arrest patients transferred to the UOEH hospital].

Murakami M, Aibara K, Nandate K, Watanabe H, Koga K, Kamochi M, Sata T, Shigematsu A. Murakami M, et al. Among authors: koga k. J UOEH. 2001 Jun 1;23(2):139-46. doi: 10.7888/juoeh.23.139. J UOEH. 2001. PMID: 11431959 Japanese.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,149 results

Search Page

Filters